The national medical regulator has concluded a recently reported case of blood clots is likely linked to the AstraZeneca COVID-19 vaccine.
It is the second Australian report of a case of so-called “thrombosis with thrombocytopenia” following the shot.
The case occurred in a woman in her 40s who was vaccinated in Western Australia.
The Therapeutic Goods Administration says the woman remains in hospital receiving treatment, and is in a stable condition.
Fears about rare blood clots prompted the federal government to last week revise its use of the AstraZeneca vaccine.
The Pfizer vaccine is now the preferred treatment for Australians under the age of 50, however, the government insists the AstraZeneca vaccine remains safe.
More to come.